Search Results - "Wilschut, J."

Refine Results
  1. 1
  2. 2
  3. 3

    High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform by Wevers, Nienke R., van Vught, Remko, Wilschut, Karlijn J., Nicolas, Arnaud, Chiang, Chiwan, Lanz, Henriette L., Trietsch, Sebastiaan J., Joore, Jos, Vulto, Paul

    Published in Scientific reports (09-12-2016)
    “…With great advances in the field of in vitro brain modelling, the challenge is now to implement these technologies for development and evaluation of new drug…”
    Get full text
    Journal Article
  4. 4

    Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels by Hol, L, Wilschut, J A, van Ballegooijen, M, van Vuuren, A J, van der Valk, H, Reijerink, J C I Y, van der Togt, A C M, Kuipers, E J, Habbema, J D F, van Leerdam, M E

    Published in British journal of cancer (07-04-2009)
    “…Immunochemical faecal occult blood testing (FIT) provides quantitative test results, which allows optimisation of the cut-off value for follow-up colonoscopy…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Human Satellite Cell Transplantation and Regeneration from Diverse Skeletal Muscles by Xu, Xiaoti, Wilschut, Karlijn J., Kouklis, Gayle, Tian, Hua, Hesse, Robert, Garland, Catharine, Sbitany, Hani, Hansen, Scott, Seth, Rahul, Knott, P. Daniel, Hoffman, William Y., Pomerantz, Jason H.

    Published in Stem cell reports (08-09-2015)
    “…Identification of human satellite cells that fulfill muscle stem cell criteria is an unmet need in regenerative medicine. This hurdle limits understanding how…”
    Get full text
    Journal Article
  7. 7

    Immediate versus staged revascularisation of non-culprit arteries in patients with acute coronary syndrome: a systematic review and meta-analysis by Vriesendorp, P. A., Wilschut, J. M., Diletti, R., Daemen, J., Kardys, I., Zijlstra, F., Van Mieghem, N. M., Bennett, J., Esposito, G., Sabate, M., den Dekker, W. K.

    Published in Netherlands heart journal (01-10-2022)
    “…Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS)…”
    Get full text
    Journal Article
  8. 8

    Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability by Lederhofer, J., van Lent, J., Bhoelan, F., Karneva, Z., de Haan, A., Wilschut, J.C., Stegmann, T.

    Published in Pharmaceutical research (01-09-2018)
    “…Purpose Characterization of virosomes, in late stage preclinical development as vaccines for Respiratory Syncytial Virus (RSV), with a membrane-incorporated…”
    Get full text
    Journal Article
  9. 9

    Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities by Amorij, J-P., Huckriede, A., Wilschut, J., Frijlink, H. W., Hinrichs, W. L. J.

    Published in Pharmaceutical research (01-06-2008)
    “…Influenza vaccination represents the cornerstone of influenza prevention. However, today all influenza vaccines are formulated as liquids that are unstable at…”
    Get full text
    Journal Article
  10. 10

    Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination by Holvast, A, Stegeman, C A, Benne, C A, Huckriede, A, Wilschut, J C, Palache, A M, Kallenberg, C G M, Bijl, M

    Published in Annals of the rheumatic diseases (01-06-2009)
    “…Wegener's granulomatosis (WG) is a systemic vasculitis characterised by relapsing and remitting disease activity. Immunosuppressive drugs are used to control…”
    Get more information
    Journal Article
  11. 11

    Cost–effectiveness of the prophylactic HPV vaccine: An application to the Netherlands taking non-cervical cancers and cross-protection into account by Luttjeboer, J, Westra, T.A, Wilschut, J.C, Nijman, H.W, Daemen, T, Postma, M.J

    Published in Vaccine (20-08-2013)
    “…Highlights • We examine the cost–effectiveness of the bivalent HPV-vaccine. • Cross-protection and protection against non-cervical cancers are taken into…”
    Get full text
    Journal Article
  12. 12

    Influenza vaccination in healthcare workers; comparison of side effects and preferred route of administration of intradermal versus intramuscular administration by Meijer, W.J, Wensing, A.M.J, Bos, A.A, Kuiphuis, J.C.F, Hagelen, E.M.M, Wilschut, J.C, de Vries, M.J.T, Riezebos-Brilman, A

    Published in Vaccine (13-03-2017)
    “…Highlights • The side effects of intradermal and intramuscular influenza vaccine are different. • Health care workers do not prefer one type of vaccine to the…”
    Get full text
    Journal Article
  13. 13

    Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands by Meijboom, M.J, Rozenbaum, M.H, Benedictus, A, Luytjes, W, Kneyber, M.C.J, Wilschut, J.C, Hak, E, Postma, M.J

    Published in Vaccine (29-06-2012)
    “…Highlights ► In the Netherlands, there is potential for RSV-vaccination of children to be cost-effective. ► Clinical research is needed on dose schedule, time…”
    Get full text
    Journal Article
  14. 14

    Isolation and characterization of porcine adult muscle-derived progenitor cells by Wilschut, Karlijn J., Jaksani, Sridevi, Van Den Dolder, Juliette, Haagsman, Henk P., Roelen, Bernard A.J.

    Published in Journal of cellular biochemistry (01-12-2008)
    “…Here, we report the isolation of progenitor cells from pig skeletal muscle tissue fragments. Muscle progenitor cells were stimulated to migrate from…”
    Get full text
    Journal Article
  15. 15

    Which factors are important in adults’ uptake of a (pre)pandemic influenza vaccine? by Zijtregtop, E.A.M, Wilschut, J, Koelma, N, Van Delden, J.J.M, Stolk, R.P, Van Steenbergen, J, Broer, J, Wolters, B, Postma, M.J, Hak, E

    Published in Vaccine (10-12-2009)
    “…Abstract Since 2008, (pre)pandemic vaccines against H5N1 influenza have been available and pandemic vaccines against new influenza H1N1 are currently produced…”
    Get full text
    Journal Article
  16. 16

    Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease by Holvast, A, Huckriede, A, Wilschut, J, Horst, G, De Vries, J J C, Benne, C A, Kallenberg, C G M, Bijl, M

    Published in Annals of the rheumatic diseases (01-07-2006)
    “…Objective: to assess the safety and efficacy of influenza vaccination in patients with systemic lupus erythematosus (SLE), and to evaluate the influence of…”
    Get full text
    Journal Article
  17. 17

    Concise Review: Stem Cell Therapy for Muscular Dystrophies by Wilschut, Karlijn J., Ling, Vivian B., Bernstein, Harold S.

    Published in Stem cells translational medicine (01-11-2012)
    “…Muscular dystrophy comprises a group of genetic diseases that cause progressive weakness and degeneration of skeletal muscle resulting from defective proteins…”
    Get full text
    Journal Article
  18. 18
  19. 19

    An update on the use of anticoagulant therapy in ST-segment elevation myocardial infarction by van Gameren, M, Lemmert, M E, Wilschut, J M, Daemen, J, De Jaegere, P P T, Zijlstra, F, Van Mieghem, N M D A, Diletti, R

    Published in Expert opinion on pharmacotherapy (02-09-2018)
    “…Together with antiplatelet therapy, anticoagulants are vital to improve outcomes in patients presenting with ST-segment elevation myocardial infarction…”
    Get more information
    Journal Article
  20. 20

    Advance notification letters increase adherence in colorectal cancer screening: A population-based randomized trial by van Roon, A.H.C., Hol, L., Wilschut, J.A., Reijerink, J.C.I.Y., van Vuuren, A.J., van Ballegooijen, M., Habbema, J.D.F., van Leerdam, M.E., Kuipers, Ernst J.

    Published in Preventive medicine (01-06-2011)
    “…The population benefit of screening depends not only on the effectiveness of the test, but also on adherence, which, for colorectal cancer (CRC) screening…”
    Get full text
    Journal Article